EDU: Other Great Highlights - 2005 ACR meeting

[Guest guest]

American College of Rheumatology 2005 Annual Scientific Meeting Highlights

http://www.medicinenet.com/script/main/art.asp?articlekey=46328 Article on

Living with Pain from the Nov 2005 American Rheumatology Conference in San

Diego.

Expert Interviews

T-Cell Costimulatory Pathway -- Targeted Inhibition and Impact on

RA Progression: An Expert Interview With Salvatore Albani, MD, PhD

Helen Fosam, PhD, Medscape Rheumatology, interviewed Salvatore Albani, MD, PhD,

on the role of targeting the costimulatory pathway as the future for treating

patients with RA.

Latest Advances in Treatment for Gout: An Expert Interview With G.

Saag, MD

Helen Fosam, PhD, Medscape Rheumatology, interviewed G. Saag, MD, on the

recent advances for treating patients with gout.

Other Conference News:

Earlier Use of Biologics, DMARDs in Juvenile Arthritis Linked to More Robust

Improvement 11/18/05

[Medscape Medical News]

Physicians have tended to use second-line agents sooner in the last few years,

with encouraging results.

Adalimumab Shows Long-term Benefits in Ankylosing Spondylitis 11/18/05

[Medscape Medical News]

The results were similar to those for other anti-TNF therapies.

Obesity and Hypertension Equalize Women's Risk of Gout after Menopause

11/17/05

[Medscape Medical News]

In the first prospective study of risk factors for gout in women, researchers

found that women with these conditions are just as likely to develop gout as

men.

Extra Prenatal Monitoring Required for Pregnant Patients With RA, Lupus

11/17/05

[Medscape Medical News]

The first nationwide study of pregnancy outcomes in these women showed that

those with either disease had a high risk of complications.

Febuxostat Has Advantages of Allopurinol and Placebo for Gout 11/17/05

[Medscape Medical News]

Because allopurinol is highly allergenic, having another xanthine oxidase

inhibitor would broaden treatment options.

Valproate Shows Promise as Lupus Treatment in Mice 11/17/05

[Medscape Medical News]

Treatment with the anti-seizure drug valproate (Depakote) can prevent the skin

disease and severe kidney manifestations seen in a murine model of lupus,

according to study findings presented Wednesday.

Rituximab Benefits RA That Does Not Respond to Anti-TNF Drugs 11/16/05

[Medscape Medical News]

Even in those with severe disease, most patients responded and some attained

remission.

Patients With Treatment-Resistant Rheumatoid Arthritis Have Sustained Response

to Abatacept 11/16/05

[Medscape Medical News]

The open-label extension of the ATTAIN study shows that most patients who did

not respond to anti-TNF agents have an ACR20 response to the investigational

biologic.

Information taken from http://www.medscape.com/viewprogram/4738

(Beautiful Southern Oregon, USA)

We may not be able to change the direction of the wind, but we can adjust our

sails.

May you have enough happiness to make you kind, enough trials to make you

strong, enough sorrow to keep you human, enough hope to make you happy.

---------------------------------

Yahoo! for Good - Make a difference this year.